Weber et al. Flow-controlled ventilation improves end-expiratory lung volume in obese patients – a crossover controlled interventional trial. Abstract #3315 presented at Euroanaesthesia 2019 – Manuscript submitted
The workgroup of Prof. Schumann revealed in a crossover randomized controlled trial that in morbidly obese patients FCV® better maintains end-expiratory lung volume as compared to VCV (P<0.001). The subsequent ventilation phases were applied for only 7 minutes, with similar tidal volumes, but lower peak inspiratory pressures for FCV®. This study indicates that FCV® may help to prevent atelectasis during mechanical ventilation.
Get back to Literature
What a fantastic closing of a great year!: Ventinova has been awarded ‘Company of the Year 2019’ by MedTech Outlook. The US-based Medical Technology Magazine annually selects the ‘Top 10 MedTech Solution Providers in Europe". Ventinova was selected as Company...